Allergic Reactions
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units
Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents
Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use
Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B